Effect of Probiotic on the Gut Microbiota of Healthy Volunteers

Sponsor
Wecare Probiotics Co., Ltd. (Industry)
Overall Status
Completed
CT.gov ID
NCT06103253
Collaborator
(none)
112
1
2
2.3
49.4

Study Details

Study Description

Brief Summary

The goal of this placebo-controlled randomized trial is to test the effect of intervention with Bifidobacterium animalis subsp. lactis BLa80 on the composition of the gut microbiota of healthy volunteers. The main question it aims to answer is whether probiotic can effectively regulate intestinal flora. Participants will take a package of probiotics every day, and their weight was recorded once a week using a weight scale. Blood and stool tests were conducted before and after taking probiotics.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: a Bla80 group
N/A

Detailed Description

This placebo-controlled study aims to investigate the effect of Bifidobacterium animalis subsp. lactis BLa80 supplementation on the status of the gut microbiota of healthy participants. 112 subjects were randomly divided into a placebo group (maltodextrin) and a Bla80 group (maltodextrin + strain BLa80 in 1 × 10 10 colony-forming units/day). The intervention lasted 8 weeks, and 16S rRNA sequencing technology was used to study the changes in gut microbiota between different groups. Simultaneously, clinical indicators such as alanine transaminase (ALT), aspartate aminotransferase (AST), and uric acid (UC) were measured to illustrate the metabolic effects of BLa80.

Study Design

Study Type:
Interventional
Actual Enrollment :
112 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Effect of Intervention With Probiotic on the Gut Microbiota of Healthy Volunteers: a Placebo-controlled Randomized Trial
Actual Study Start Date :
Apr 20, 2023
Actual Primary Completion Date :
Apr 25, 2023
Actual Study Completion Date :
Jun 28, 2023

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Placebo group

a placebo 27 group (maltodextrin)

Dietary Supplement: a Bla80 group
the BLa80 group received 2.9 g of maltodextrin + 0.1 g of BLa80 bacterial powder 10B daily.

Active Comparator: Probiotic group

a Bla80 group (maltodextrin + strain BLa80 in 10B /day)

Dietary Supplement: a Bla80 group
the BLa80 group received 2.9 g of maltodextrin + 0.1 g of BLa80 bacterial powder 10B daily.

Outcome Measures

Primary Outcome Measures

  1. gut microbiota diversity [8 weeks]

    Before and after taking probiotics, subjects' stool was collected, and stool 16s rRNA was detected by DNA extraction kit.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • BMI ≥ 21
Exclusion Criteria:
  • Those who have been diagnosed with diabetes or have high blood sugar are not recommended to participate in the test;

  • People whose daily diet is too light or too greasy are not recommended to participate in the test; People with special dietary structure caused by weight loss or other reasons (such as ketogenic diet, etc.) are not recommended to participate in the test;

  • Other people with special circumstances are not recommended to participate, such as those who are allergic to probiotic products; Pregnant women, breastfeeding women and people under 19 years old and over 45 years old should not be tested.

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Engineering Laboratory for Deep Processing of wheat and corn Zhengzhou Henan China 450001

Sponsors and Collaborators

  • Wecare Probiotics Co., Ltd.

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wecare Probiotics Co., Ltd.
ClinicalTrials.gov Identifier:
NCT06103253
Other Study ID Numbers:
  • WK2023005
First Posted:
Oct 26, 2023
Last Update Posted:
Oct 26, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wecare Probiotics Co., Ltd.

Study Results

No Results Posted as of Oct 26, 2023